Home » News » CROs/Service Providers » Huntingdon Life Sciences acquires Harlan Laboratories

Huntingdon Life Sciences acquires Harlan Laboratories

Friday, May 2, 2014

Huntingdon Life Sciences has acquired Harlan Laboratories, a privately held provider of general and specialty toxicology services. The new company will have two operating divisions: Research Models and Services and Contract Research Services.

This acquisition creates a global organization offering full-service, non-clinical, contract research and research models and services. The increased scale of the combined venture, approaching half a billion dollars in annual revenue, provides a strong platform for future growth and investment.

Brian Cass, CEO of Huntingdon Life Sciences, said, “This acquisition is precisely in line with our strategy to broaden our support for the pharmaceutical, crop protection and chemical industries, as well as universities, government and other research organizations.”

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!